BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 37756366)

  • 21. Deferasirox and vitamin D
    Ghaith MM; El-Boshy M; Almasmoum H; Abdelghany AH; Azzeh FS; Almaimani RA; Idris S; Ahmad J; Mahbub AA; BaSalamah MA; Elzubeir ME; Refaat B
    J Trace Elem Med Biol; 2022 Dec; 74():127085. PubMed ID: 36179462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, β-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation.
    Dash UC; Swain SK; Kanhar S; Banjare P; Roy PP; Dandapat J; Sahoo AK
    J Ethnopharmacol; 2022 Jan; 282():114637. PubMed ID: 34534598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective Effects of Fucoidan on Aβ25-35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice.
    Wei H; Gao Z; Zheng L; Zhang C; Liu Z; Yang Y; Teng H; Hou L; Yin Y; Zou X
    Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28300775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis.
    Moslemi E; Musazadeh V; Kavyani Z; Naghsh N; Shoura SMS; Dehghan P
    Pharmacol Res; 2022 Dec; 186():106484. PubMed ID: 36206958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Foroozanfard F; Jamilian M; Bahmani F; Talaee R; Talaee N; Hashemi T; Nasri K; Asemi Z; Esmaillzadeh A
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):888-94. PubMed ID: 26119844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
    Kang J; Park M; Kim T
    J Alzheimers Dis; 2024; 97(4):1939-1950. PubMed ID: 38339931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dioscin alleviates Alzheimer's disease through regulating RAGE/NOX4 mediated oxidative stress and inflammation.
    Guan L; Mao Z; Yang S; Wu G; Chen Y; Yin L; Qi Y; Han L; Xu L
    Biomed Pharmacother; 2022 Aug; 152():113248. PubMed ID: 35691153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes.
    Gu JC; Wu YG; Huang WG; Fan XJ; Chen XH; Zhou B; Lin ZJ; Feng XL
    J Clin Lab Anal; 2022 May; 36(5):e24430. PubMed ID: 35403296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.
    Plascencia-Villa G; Perry G
    Antioxid Redox Signal; 2021 Mar; 34(8):591-610. PubMed ID: 32486897
    [No Abstract]   [Full Text] [Related]  

  • 32. Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focus on its combination with donepezil.
    Elseweidy MM; Mahrous M; Ali SI; Shaheen MA; Younis NN
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1931-1942. PubMed ID: 36864348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease.
    Peter C; Braidy N; Zarka M; Welch J; Bridge W
    Curr Alzheimer Res; 2015; 12(4):298-313. PubMed ID: 25731620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-Related Oxidative Redox and Metabolic Changes Precede Intraneuronal Amyloid-β Accumulation and Plaque Deposition in a Transgenic Alzheimer's Disease Mouse Model.
    Pontrello CG; McWhirt JM; Glabe CG; Brewer GJ
    J Alzheimers Dis; 2022; 90(4):1501-1521. PubMed ID: 36278355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
    Jain SK; Parsanathan R; Levine SN; Bocchini JA; Holick MF; Vanchiere JA
    Free Radic Biol Med; 2020 Dec; 161():84-91. PubMed ID: 33038530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.
    Wei Y; Liu D; Zheng Y; Li H; Hao C; Ouyang W
    Brain Res Bull; 2017 Sep; 134():262-272. PubMed ID: 28867383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative D3 vitamin deficiency and consequent cognitive impairment in an animal model of Alzheimer's disease: Potential involvement of collapsin response mediator protein-2.
    Lin FY; Lin YF; Lin YS; Yang CM; Wang CC; Hsiao YH
    Neuropharmacology; 2020 Mar; 164():107910. PubMed ID: 31838171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant pathways in Alzheimer's disease: possibilities of intervention.
    Viña J; Lloret A; Giraldo E; Badia MC; Alonso MD
    Curr Pharm Des; 2011 Dec; 17(35):3861-4. PubMed ID: 21933145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.